FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561528181> ?p ?o ?g. }

• W2561528181 abstract "Abstract RIC regimens followed by allogeneic SCT have demonstrated to induce complete donor chimerism and long-term survival with decreased transplant-related mortality in adults with poor-risk hematological malignancies. Pediatric experience of RIC regimens is mostly reported in children with non malignant diseases in whom late long-term complications should be reduced. There are only limited data in children with malignancies, ineligible for conventional SCT. We conducted a retrospective survey of 28 children who underwent a RIC regimen for a malignant hematological disease (18 AL, 2 RAEBt, 1 CML, 3 NHL, 2 HD) or a solid tumor (1 Ewing sarcoma, 1 rhabdomyosarcoma) from 1998 to 2004 in 11 participating hospitals. All children had contraindications against myeloablative regimen. Median age was 14 years. Fourteen patients (pts) had an advanced disease (&gt; CR2, refractory or progressive).Ten pts had already undergone at least one transplantation. Most RIC were fludarabine-based (n= 26). Nineteen children received additional anti-thymocyte globulin and 4 were transplanted with a T-depleted graft. Source of hematopoietic stem cell was marrow (n= 17), peripheral blood (n= 9) or cord blood (n= 2). Donor was matched related (n= 12) or unrelated (n= 8), mismatched related (n= 2) or unrelated (n= 6). Median follow-up after SCT is 142 days (range: 22–2345). Engraftment was observed in all 25 valuable pts. Day-90 chimerism analysis was performed in 18 pts and showed complete donor cells in 12 and autologous reconstitution in 3 pts. Grade II–IV aGVHD and cGVHD developed in 8/25 and 3/16 valuable pts, respectively. The day-100 transplant-related mortality rate was 18%. Disease progression or relapse occurred in 13 pts. Nineteen pts died: 11 from initial disease, 2 from infection, 2 from GVHD, 4 from other toxic complication. Four pts underwent a second transplantation for relapse or autologous reconstitution (3 myeloablative, 1RIC SCT). Five pts are alive in CR 145, 336, 782, 993, 2345 days after a first transplantation, 2 pts 272 and 1062 days after a second transplantation. Only 1 child among the 14 with an advanced disease is alive versus 6 among those with a lower-risk disease. In conclusion, allogeneic SCT with RIC is feasible in heavily pre-treated children. In order to reduce the high incidence of relapse, further prospective studies are needed to determine best pts selection criteria (initial diagnosis, treatment prior to transplant, chemosensitivity of the disease) and the best transplantation strategy (timing, type of the RIC, post-transplant additional treatment)." @default.
• W2561528181 created "2017-01-06" @default.
• W2561528181 creator A5000858647 @default.
• W2561528181 creator A5001526915 @default.
• W2561528181 creator A5004015988 @default.
• W2561528181 creator A5007485886 @default.
• W2561528181 creator A5011992727 @default.
• W2561528181 creator A5014678847 @default.
• W2561528181 creator A5029435774 @default.
• W2561528181 creator A5032410204 @default.
• W2561528181 creator A5037737991 @default.
• W2561528181 creator A5070058945 @default.
• W2561528181 creator A5072557528 @default.
• W2561528181 creator A5072757261 @default.
• W2561528181 date "2005-11-16" @default.
• W2561528181 modified "2023-10-18" @default.
• W2561528181 title "Allogeneic Stem Cell Transplantation (SCT) with Reduced-Intensity Conditioning (RIC) in Children with Malignancies: A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)." @default.
• W2561528181 doi "https://doi.org/10.1182/blood.v106.11.3670.3670" @default.
• W2561528181 hasPublicationYear "2005" @default.
• W2561528181 type Work @default.
• W2561528181 sameAs 2561528181 @default.
• W2561528181 citedByCount "0" @default.
• W2561528181 crossrefType "journal-article" @default.
• W2561528181 hasAuthorship W2561528181A5000858647 @default.
• W2561528181 hasAuthorship W2561528181A5001526915 @default.
• W2561528181 hasAuthorship W2561528181A5004015988 @default.
• W2561528181 hasAuthorship W2561528181A5007485886 @default.
• W2561528181 hasAuthorship W2561528181A5011992727 @default.
• W2561528181 hasAuthorship W2561528181A5014678847 @default.
• W2561528181 hasAuthorship W2561528181A5029435774 @default.
• W2561528181 hasAuthorship W2561528181A5032410204 @default.
• W2561528181 hasAuthorship W2561528181A5037737991 @default.
• W2561528181 hasAuthorship W2561528181A5070058945 @default.
• W2561528181 hasAuthorship W2561528181A5072557528 @default.
• W2561528181 hasAuthorship W2561528181A5072757261 @default.
• W2561528181 hasConcept C126322002 @default.
• W2561528181 hasConcept C141071460 @default.
• W2561528181 hasConcept C2776694085 @default.
• W2561528181 hasConcept C2776755627 @default.
• W2561528181 hasConcept C2777408962 @default.
• W2561528181 hasConcept C2779263901 @default.
• W2561528181 hasConcept C2779709957 @default.
• W2561528181 hasConcept C2780914630 @default.
• W2561528181 hasConcept C2781413609 @default.
• W2561528181 hasConcept C2911091166 @default.
• W2561528181 hasConcept C71924100 @default.
• W2561528181 hasConcept C90924648 @default.
• W2561528181 hasConceptScore W2561528181C126322002 @default.
• W2561528181 hasConceptScore W2561528181C141071460 @default.
• W2561528181 hasConceptScore W2561528181C2776694085 @default.
• W2561528181 hasConceptScore W2561528181C2776755627 @default.
• W2561528181 hasConceptScore W2561528181C2777408962 @default.
• W2561528181 hasConceptScore W2561528181C2779263901 @default.
• W2561528181 hasConceptScore W2561528181C2779709957 @default.
• W2561528181 hasConceptScore W2561528181C2780914630 @default.
• W2561528181 hasConceptScore W2561528181C2781413609 @default.
• W2561528181 hasConceptScore W2561528181C2911091166 @default.
• W2561528181 hasConceptScore W2561528181C71924100 @default.
• W2561528181 hasConceptScore W2561528181C90924648 @default.
• W2561528181 hasLocation W25615281811 @default.
• W2561528181 hasOpenAccess W2561528181 @default.
• W2561528181 hasPrimaryLocation W25615281811 @default.
• W2561528181 hasRelatedWork W2081782066 @default.
• W2561528181 hasRelatedWork W2360634842 @default.
• W2561528181 hasRelatedWork W2536542389 @default.
• W2561528181 hasRelatedWork W2538500352 @default.
• W2561528181 hasRelatedWork W2751136461 @default.
• W2561528181 hasRelatedWork W2762023563 @default.
• W2561528181 hasRelatedWork W3081018185 @default.
• W2561528181 hasRelatedWork W3137364747 @default.
• W2561528181 hasRelatedWork W3174720739 @default.
• W2561528181 hasRelatedWork W3213199609 @default.
• W2561528181 isParatext "false" @default.
• W2561528181 isRetracted "false" @default.
• W2561528181 magId "2561528181" @default.
• W2561528181 workType "article" @default.